Pulmicort Asthma Prevention (Post-PAC)

Study identifier:D5254C00004

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A study to evaluate the feasibility of a treatment algorithm in newly diagnosed asthmatic children. An open follow-up to Asthma Prevention in infants/young children (PAC)

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

400

Study type

Interventional

Age

0 Months - 6 Years

Date

Study Start Date: 01 Jul 2001
Primary Completion Date: 01 May 2006
Study Completion Date: 01 Jun 2006

Study design

Allocation: Non-randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Jan 2008 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria